PHATHOM PHARMACEUTICALS, INC. Depreciation
PHATHOM PHARMACEUTICALS, INC. (PHAT) reported Depreciation of $100.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow
us-gaap:Depreciation · last filed 2023-11-09
- PHATHOM PHARMACEUTICALS, INC. depreciation for the quarter ending 2023-09-30 was $100.00K, a 50.00% decline year-over-year.
- PHATHOM PHARMACEUTICALS, INC. depreciation for the quarter ending 2023-06-30 was $100.00K, a 0.00% change year-over-year.
- PHATHOM PHARMACEUTICALS, INC. depreciation for the quarter ending 2023-03-31 was $100.00K, a 0.00% change year-over-year.
- PHATHOM PHARMACEUTICALS, INC. depreciation for the quarter ending 2022-12-31 was $100.00K, a 12.28% decline year-over-year.
- PHATHOM PHARMACEUTICALS, INC. depreciation for fiscal 2022 was $600.00K, a 20.00% increase from fiscal 2021.
- PHATHOM PHARMACEUTICALS, INC. depreciation for fiscal 2021 was $500.00K, a 66.67% increase from fiscal 2020.
- PHATHOM PHARMACEUTICALS, INC. depreciation for fiscal 2020 was $300.00K, a 3650.00% increase from fiscal 2019.
- PHATHOM PHARMACEUTICALS, INC. depreciation for fiscal 2019 was $8.00K.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|---|---|
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-09 | $200.00K derived: sum of 2 quarters · filed 2023-11-09 | $400.00K 10-Q · filed 2023-11-09 | $400.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2023-06-30 | $100.00K 10-Q · filed 2023-08-10 | $300.00K 10-Q · filed 2023-08-10 | $300.00K derived: sum of 3 quarters · filed 2023-08-10 | $500.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2023-03-31 | $100.00K 10-Q · filed 2023-05-10 | $200.00K derived: sum of 2 quarters · filed 2023-05-10 | $400.00K derived: sum of 3 quarters · filed 2023-11-09 | $500.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $300.00K derived: sum of 2 quarters · filed 2023-11-09 | $400.00K derived: sum of 3 quarters · filed 2023-11-09 | $600.00K 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-09 | $175.00K 10-Q · filed 2022-11-08 | $300.00K derived: sum of 2 quarters · filed 2023-11-09 | $500.00K 10-Q · filed 2023-11-09 | $452.00K 10-Q · filed 2022-11-08 | $514.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-10 | $149.00K 10-Q · filed 2022-08-02 | $300.00K 10-Q · filed 2023-08-10 | $277.00K 10-Q · filed 2022-08-02 | $314.00K derived: sum of 3 quarters · filed 2023-08-10 | $444.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-10 | $128.00K 10-Q · filed 2022-05-10 | $214.00K derived: sum of 2 quarters · filed 2023-05-10 | $344.00K derived: sum of 3 quarters · filed 2023-05-10 | $475.00K derived: sum of 4 quarters · filed 2023-05-10 | ||
| 2021-12-31 | $114.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-02-28 | $244.00K derived: sum of 2 quarters · filed 2023-02-28 | $375.00K derived: sum of 3 quarters · filed 2023-02-28 | $500.00K 10-K · filed 2023-02-28 | |||
| 2021-09-30 | $130.00K 10-Q/A · filed 2022-11-09 | $261.00K derived: sum of 2 quarters · filed 2022-11-09 | $386.00K 10-Q/A · filed 2022-11-09 | $469.00K derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | $131.00K 10-Q · filed 2022-08-02 | $256.00K 10-Q · filed 2022-08-02 | $339.00K derived: sum of 3 quarters · filed 2022-08-02 | $427.00K derived: sum of 4 quarters · filed 2022-08-02 | |||
| 2021-03-31 | $125.00K 10-Q · filed 2022-05-10 | $208.00K derived: sum of 2 quarters · filed 2022-05-10 | $296.00K derived: sum of 3 quarters · filed 2022-05-10 | $373.00K derived: sum of 4 quarters · filed 2022-05-10 | |||
| 2020-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $171.00K derived: sum of 2 quarters · filed 2022-03-01 | $248.00K derived: sum of 3 quarters · filed 2022-03-01 | $300.00K 10-K · filed 2022-03-01 | |||
| 2020-09-30 | $88.00K 10-Q · filed 2021-11-08 | $165.00K derived: sum of 2 quarters · filed 2021-11-08 | $217.00K 10-Q · filed 2021-11-08 | $223.00K derived: sum of 4 quarters · filed 2021-11-08 | |||
| 2020-06-30 | $77.00K 10-Q · filed 2021-08-10 | $129.00K 10-Q · filed 2021-08-10 | $135.00K derived: sum of 3 quarters · filed 2021-08-10 | $137.00K derived: sum of 4 quarters · filed 2021-08-10 | |||
| 2020-03-31 | $52.00K 10-Q · filed 2021-05-11 | $58.00K derived: sum of 2 quarters · filed 2021-05-11 | $60.00K derived: sum of 3 quarters · filed 2021-05-11 | $60.00K derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $8.00K derived: sum of 2 quarters · filed 2021-03-30 | $8.00K derived: sum of 3 quarters · filed 2021-03-30 | $8.00K 10-K · filed 2021-03-30 | |||
| 2019-09-30 | $2.00K 10-Q · filed 2020-11-10 | $2.00K derived: sum of 2 quarters · filed 2020-11-10 | $2.00K 10-Q · filed 2020-11-10 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-12 | ||||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |